IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2025.117656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Maieryemu Waresi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Interleukin-18, Thrombosis, Platelet Activation, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Arterial thrombosis is a leading cause of global cardiovascular mortality. Clinical evidence indicates that elevated IL-18 levels independently predict cardiovascular events, yet its direct role in thrombosis is poorly understood. Hence, targeting IL-18 could be a novel therapeutic strategy. This study investigated the mechanism of IL-18 in platelet activation and evaluated the antithrombotic efficacy of interleukin-18 binding protein (IL-18BP). Through in vitro and in vivo models, including Il18r1-/- mice, we demonstrated that IL-18 enhances platelet activation and thrombus formation via its receptor interleukin-18 receptor alpha (IL-18Rα). This action was mediated through the potentiation of MAPKs and PI3K/Akt signaling. Strikingly, IL-18BP exhibited superior antiplatelet effects in both mouse models and human subjects, including those with coronary artery disease (CAD). Our findings reveal that IL-18 is a key promoter of thrombosis and identify IL-18BP as a highly effective, targeted therapy for cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Biochemistry and Molecular Biology, NHC Key Laboratory of Glycoconjugates Research, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: huangchaoyang75@126.com.
- Department of Hematology, Zhongshan Hospital (Qingpu Branch), Fudan University, Shanghai, China. Electronic address: 20211010013@fudan.edu.cn.
- Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: gxg22222@zju.edu.cn.
- Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: 18211220018@fudan.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Waresi, M., Zhou, H., Jiao, C., Hu, J., Shi, M., Lin, X., Ye, T., Huang, C., Zhang, W., Guo, X., & Zhong, H. (2026). IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117656
Vancouver
Waresi M, Zhou H, Jiao C, Hu J, Shi M, Lin X, et al. IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117656
BibTeX
@article{Waresi2026,
author = {Waresi, Maieryemu and Zhou, Huili and Jiao, Can and Hu, Jingjing and Shi, Mengsha and Lin, Xuanhan and Ye, Tianxin and Huang, Chaoyang and Zhang, Wei and Guo, Xiaogang and Zhong, Haoxuan},
title = {IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2025.117656}
}
EUVIMED